Highly Potent API Market Outlook
$5,650.00 – $11,300.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
Welcome to ISR's Highly Potent API Manufacturing Market Outlook report. Highly potent active pharmaceutical ingredients (HPAPIs) are a growing area for pharmaceutical companies. This report provides an overview of the current market dynamics for high containment manufacturing as well as an outlook on what our survey respondents—all HPAPI manufacturing decision-makers at sponsor organizations—predict the marketplace will look like five years from now.
Key statistics include respondents' categorizations of their companies' high containment assets and the proportion of their small molecule portfolio that requires high containment manufacturing, the number of compounds requiring high containment that are in respondents' development pipelines and on the market, which therapeutic areas they are designed to target, and the outsourcing prevalence of each type of high containment asset. As a drug innovator, discover how industry peers are selecting service providers and which aspects of the manufacturing process have been most challenging. As a CDMO, determine how your capabilities and marketing messaging stack up against what highly potent manufacturing outsourcers regard as important as well as the main reasons CDMOs lose the bid for an HPAPI project.
What you will learn:
Drug Developers:
- Gain insight into where the highly potent drug substance industry is heading over the next five years with respect to the outsourcing penetration across different manufacturing activities and types of high containment compounds
- Understand the CDMO usage patterns of industry peers to identify whether additional outsourcing advantages can be obtained for your organization
- Learn the criteria used by peers to help scientifically and strategically evaluate CDMOs for highly potent drug substance projects
Contract Manufacturers:
- Pinpoint which CDMO attributes have led to successful outsourcing relationships, those that have caused service providers to lose bids and what truly drives sponsor satisfaction, then internally assess your company on these metrics
- Identify changes in demand for outsourced activities and services in order to prepare for future needs
- Better position your company to win business by understanding the dynamics of different buyer groups and developing targeted marketing to speak directly to their unique needs
Major Topics:
- Market Dynamics
- Outsourcing Practices
- Trends, Predictions, Preferences
- Study Data
- Demographics